KUALA LUMPUR, July 21 (Bernama) -- Blue California has joined with the innovative Massachusetts-based biotech company Conagen to announce commercialisation of high-purity, fermentation-derived nicotinamide mononucleotide (NMN).
NMN is a nature-based metabolic component which has caught the attention of health-conscious consumers for supporting energy and longevity, according to a statement.
NMN supplements are highly sought-after for healthy aging applications, including brain health, vitality, heart health, metabolic health, and even cosmetics. However, current NMN ingredients used in products on the market are mostly produced by chemical synthesis.
“Our fermentation-derived offering is well-positioned to capitalise on the growing recognition of NMN as an important ingredient in the food and supplement spaces,” said Chief Science Officer at Blue California, Dr Priscilla Samuel.
“Because of the way we make it, Conagen’s NMN is of the highest purity and quality. It is also very cost-effective and compatible with clean-label trends, all of which demonstrates our strength as a strategic partner with Blue California,” said VP of Innovation at Conagen, Dr Casey Lippmeier.
While consumers are exploring dietary supplements for a holistic approach to health, they are also demanding clean labels from their supplements, and moving away from synthetic ingredients.
Blue California’s fermentation-derived NMN opens new opportunities for producers to consider consumers' health more holistically while acquiring a closer-to-nature position.
NMN serves as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme present in all living cells and critical for mitochondrial function.
Increased intracellular levels of NAD+ boost energy production and improve cellular health, but levels decline dramatically with age.
Replenishing NAD+ in the body with its precursor NMN has been proposed as a way to possibly combat age-related degeneration and increase healthy lifespan.
More details at www.bluecal-ingredients.com.
-- BERNAMA
No comments:
Post a Comment